Brain lesions in multiple sclerosis are areas of damage in the brain where the immune system has attacked the protective coating around nerve fibers. These patches of damage, visible on MRI scans, are the hallmark of MS and the primary tool doctors use to diagnose the condition, track its progression, and judge whether treatment is working. Understanding what these lesions are, where they form, and what they mean can help you make sense of your MRI results and what your neurologist is watching for.
How MS Lesions Form
Nerve fibers in the brain are wrapped in a fatty insulation called myelin, which allows electrical signals to travel quickly between neurons. In MS, the immune system mistakenly treats myelin as a threat. White blood cells cross the blood-brain barrier, the protective boundary that normally keeps immune cells out of the brain, and attack the myelin sheath. This process is called demyelination.
The result is a lesion: a patch of inflammation and tissue damage that disrupts the nerve signals passing through that area. Think of it like a section of electrical wire with its insulation stripped away. Signals slow down, misfire, or stop entirely. Early on, the brain can sometimes repair the myelin (a process called remyelination), and symptoms may improve. Over time, though, repeated attacks in the same area can destroy not just the insulation but the nerve fibers themselves, leading to permanent damage.
Where Lesions Typically Appear
MS lesions don’t appear randomly. They cluster around small veins in specific parts of the brain, which is one reason their location helps distinguish MS from other conditions. The current diagnostic criteria (the McDonald criteria, revised in 2017) require lesions in at least two of four characteristic regions to confirm the disease has spread across space in the nervous system:
- Periventricular: directly bordering the fluid-filled ventricles deep in the brain. These are the most common MS lesions, averaging about 6 to 7 per person at the time of diagnosis. They form around the small veins lining the ventricle walls.
- Juxtacortical or cortical: touching or within the outer layer of the brain (the cortex). These form around superficial veins near the brain’s surface.
- Infratentorial: in the brainstem, cerebellum, or the connections between them, located in the lower part of the skull. These are less numerous, averaging about 1 to 2 at diagnosis, but can cause disproportionate symptoms because this region controls vital functions like balance and eye movement.
- Spinal cord: lesions in the spinal cord, which can cause numbness, weakness, or problems with bladder and bowel control.
Lesions also tend to beget more lesions in the same neighborhood. Research shows that new lesions in a given region are positively associated with the number of lesions already present there, meaning areas that are already affected are more likely to develop additional damage over time.
What Different Lesion Types Mean on MRI
Not all lesions look the same on MRI, and the differences matter. Your neurologist uses different scan types to classify lesions by their age and severity.
Active (Enhancing) Lesions
During an MRI, a contrast dye called gadolinium is injected into a vein. Normally, the blood-brain barrier blocks this dye from entering brain tissue. But when a lesion is actively inflamed, the barrier breaks down, and the dye leaks in, making the lesion “light up” on the scan. These gadolinium-enhancing lesions are the reference standard for detecting active inflammation in MS. They represent new or currently worsening damage and are a key sign that the disease is active right now.
T2 Lesions
A different type of MRI sequence (called T2-weighted or FLAIR) shows the total burden of disease: every lesion that has ever formed and left a mark, whether it’s currently inflamed or not. These appear as bright white spots. The total number and volume of T2 lesions gives your neurologist a picture of cumulative damage over time. New T2 lesions appearing between scans indicate disease activity even if you haven’t noticed new symptoms.
Black Holes
On yet another MRI sequence (T1-weighted), some older lesions appear as dark spots, often called “black holes.” These are the most concerning type because they correspond to permanent nerve fiber destruction rather than just damaged insulation. Black holes have high water content, reflecting tissue that has been lost entirely. The number of black holes correlates with physical disability, and their accumulation over time is also linked to brain shrinkage (atrophy). Not every old lesion becomes a black hole; some heal well enough to appear normal on T1 scans, which is actually a good sign.
How Lesion Location Affects Symptoms
The symptoms a lesion causes depend entirely on where it sits in the brain. A small lesion in the brainstem can cause more noticeable problems than a larger one in a “quiet” area of white matter near the ventricles. This is why two people with the same number of lesions can have very different experiences with MS.
Brainstem lesions in MS tend to appear in the midbrain and pons and are often scattered in a patchy pattern near the edges of the brainstem. They commonly cause double vision, abnormal eye movements (including a characteristic problem where the eyes don’t coordinate properly when looking to the side), vertigo, slurred speech, difficulty swallowing, and facial numbness. Cerebellar lesions affect coordination and balance, causing unsteady walking and tremor. Periventricular lesions, while the most common, may cause subtler problems like fatigue, cognitive slowing, or difficulty concentrating. Lesions near the cortex can affect sensation, movement, or higher-level thinking depending on their precise location.
It’s also worth knowing that many lesions cause no obvious symptoms at all. These “silent” lesions are still doing damage, which is one reason neurologists monitor MRI scans even when you feel fine.
How Lesion Burden Relates to Disability
Researchers have tracked the relationship between what MRI scans show and how people with MS do over time. A landmark longitudinal study published in the New England Journal of Medicine found that lesion volume in the first five years after diagnosis correlated moderately with disability at 14 years (a correlation of 0.60 on a scale where 1.0 would be perfect). The number and volume of lesions at baseline also correlated with disability at 10 years, though more modestly (0.45).
These are meaningful but imperfect relationships. Lesion counts and volumes tell part of the story, but not all of it. Brain atrophy, spinal cord damage, and microscopic changes invisible on standard MRI also contribute to disability. This is why someone with a high lesion count might be doing relatively well, while someone with fewer visible lesions might struggle more, particularly if they have significant black holes or spinal cord involvement.
Chronic Active Lesions
A newer area of focus involves lesions that appear quiet on standard MRI but are still slowly expanding and causing damage. These are called chronic active lesions, sometimes described as “smoldering” lesions. On specialized MRI sequences, they show a distinct dark rim made up of iron-laden immune cells (microglia) at their edges. These paramagnetic rim lesions, also known as iron rim lesions, represent ongoing low-grade inflammation that persists even between relapses.
This type of lesion is thought to be a marker of the slow, progressive damage that continues in MS even when there are no obvious flare-ups. Identifying them is becoming an increasingly important part of understanding why some people worsen gradually despite appearing stable on standard scans. Detecting these lesions currently requires specific MRI techniques and higher-strength scanners, so they aren’t yet part of routine clinical monitoring everywhere.
How Treatment Affects Lesion Activity
One of the main goals of MS treatment is reducing new lesion formation. Disease-modifying therapies work by calming or redirecting the immune system to prevent it from attacking myelin. The effectiveness of these treatments is often measured by how much they reduce new lesion activity on MRI.
Starting high-efficacy treatment early makes a substantial difference. Research comparing early aggressive treatment to a more gradual approach found that the risk of developing a new MRI lesion dropped by 77% in people who began high-efficacy therapy from the start. This is why neurologists pay close attention to MRI scans after starting or switching treatments. If new enhancing or T2 lesions keep appearing, it’s a signal that the current therapy isn’t controlling the disease well enough, and a change may be needed.
Existing lesions, particularly black holes, don’t disappear with treatment. The goal is preventing new ones from forming and slowing the accumulation of damage. This makes early and consistent monitoring with MRI one of the most important tools in MS management, often catching disease activity before new symptoms ever appear.